Engagement in a diabetes control program & clinical biomarkers in diverse municipality workers

34.1 million adults (18 years or older) have diabetes (13.0% of US adults) according to the CDC (2020). Diabetes is complex and associated with comorbidities which requires both lifestyle changes and medication to successfully manage the condition (World Health Organization, 2016). The purpose of this dissertation is to investigate the engagement in, and impact of, a workplace diabetes control program while measuring clinical health biomarkers and healthcare utilization in a municipality. Secondary data analysis was conducted using a de-identified clinical dataset that was collected from the City of Austin (COA) Diabetes Control Program (DCP). Most participants enrolling in the COA DCP were engaged, completing three or more pharmacy visits during both 2018 (85%) & 2019 (86%). Most participants during both 2018 (64%) & 2019 (59%) had baseline HbA1c values < 7%, signifying glycemic control, with averages for 2018 & 2019 respectively (6.7 ± 1.3 & 6.9 ± 1.3). There were significant differences between 2018 & 2019 baseline values in body mass (2018: 98.1± 22.3 kg; 2019: 97.1± 21.1 kg), HbA1c (2018: 6.7 ± 1.3; 2019: 6.9 ± 1.3), LDL (2018: 54.4 ± 23.9 mg/dL; 2019: 49.8 ± 22.3 mg/dL), total cholesterol (2018: 146.6 ± 34.2 mg/dL; 2019: 137.2± 34.9mg/dL) and triglycerides (2018: 175.9± 100.2 mg/dL; 2019: 144.7±90.6 mg/dL) (p